In UK alone, chronic migraine affects more than six lakh people. And even though a number of treatment options exist to reduce the intensity of the symptoms, there is no definitive solution for it. The first drug to prevent migraine has been approved by European health officials. According to a report in The Guardian, the drug Erenumab